Natco Pharma Financials Statement

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Jun-2023	Mar-2023	Dec-2022	Sep-2022	Jun-2022
Gross Sales	1140.50	897.90	492.50	432.10	884.60
Excise Duty	--	--	--	--	--
Net Sales	1140.50	897.90	492.50	432.10	884.60
Other Operating Income	--	--	--	--	--
Other Income	19.70	29	20.80	20.50	34.30
Total Income	1160.20	926.90	513.30	452.60	918.90
Total Expenditure	612.50	558.80	386.60	336.80	489.30
PBIDT	547.70	368.10	126.70	115.80	429.60
Interest	4.20	2.70	3.80	3.80	4.20
PBDT	543.50	365.40	122.90	112	425.40
Depreciation	43.50	41	41.50	41.70	39.60
Minority Interest Before NP	--	--	--	--	--
Tax	92.10	58.30	18.20	14.10	72.10
Deferred Tax	(12.40)	(9.70)	0.90	(0.60)	(6.70)
Reported Profit After Tax	420.30	275.80	62.30	56.80	320.40
Minority Interest After NP	--	--	--	--	--
Net Profit after Minority Interest	420.30	275.80	62.30	56.80	320.40
Extra-ordinary Items	--	--	--	--	--
Adjusted Profit After Extra-ordinary item	420.30	275.80	62.30	56.80	320.40
EPS (Unit Curr.)	23.26	15.11	3.41	3.11	22.55
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	350	--	62.50	37.50	175
Equity	35.80	36.50	36.50	36.50	36.50
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	48.02	41.00	25.73	26.80	48.56
PBDTM(%)	47.66	40.70	24.95	25.92	48.09
PATM(%)	36.85	30.72	12.65	13.14	36.22

QuickLinks for Natco Pharma Ltd.